EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Which is the best timing to assess response after chemoradiation in locally advanced cervical cancer (BRILACC)?

Rosa Autorino, Gabriella Macchia, Luca Russo, Nicola Dinapoli, Valentina Lancellotta, Nicolò Bizzarri, Maria Gabriella Ferrandina, Maura Campitelli, Viola De Luca, Roberta Giannini, Raffaella Michela Rinaldi, Evis Sala und 2 weitere

Strahlentherapie und Onkologie · 2025

DOI: 10.1007/s00066-025-02463-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Strahlentherapie und Onkologie, 2025. Verfasst von Rosa Autorino und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Chemoradiotherapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The goal is to investigate the best time point for assessing radiological complete response after exclusive chemoradiation in locally advanced cervical cancer (LACC). This is a retrospective single-center study. MATERIALS AND METHODS: Seventy-nine patients with LACC, stage IB3-IVA FIGO 2018 treated between January and December 2020 were retrospectively analyzed. All patients received external beam radiotherapy (45 Gy in 25 daily fractions ± simultaneous boost to lymph nodes), and interventional radiotherapy (IRT, 28 Gy/twice/weekly) with concurrent chemotherapy. The radiological complete response evaluation was examined using magnetic resonance imaging (MRI) at three timepoints: (i) before IRT, at the end of external beam radiotherapy, (ii) 3 months following the completion of IRT and (iii) 6 months after IRT. Seventy-nine patients were included. RESULTS: At the three timepoints, the complete response rate increased with 21, 53, and 59 patients reporting a complete response at MRI scan, respectively. Seven patients with partial response at the second assessment had complete response 6 months after treatment completion, overall resulting in 80% clinical complete response. CONCLUSIONS: Our findings suggest that 6 months following the end of exclusive treatment for LACC patients is the best time to detect complete radiological response (measured by MRI scan) after chemoradiation. Waiting this period of time before conclusively assessing response would allow for the inclusion of patients who have not yet fully responded at 3 months, while avoiding the performance of salvage therapies too early.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsChemoradiotherapyHumansFemaleMiddle AgedRetrospective StudiesMagnetic Resonance ImagingAdultAgedNeoplasm StagingTreatment OutcomeTime Factors

Stichwörter der Autor:innen

Magnetic resonance imagingRadiological complete timing responseSalvage therapyTumor responseUterine cervical neoplasms

Autor:innen und Institutionen

  • Department of Radiation Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • UOC Radiation Oncology Unit, Responsible Research Hospital, Campobasso, Italy.
  • Department of Bioimaging, Radiation Oncology and Hematology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • UOC Ginecologia Oncologica, Dipartimento per la salute della Donna e del Bambino e della Salute Pubblica, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
  • Department of Radiation Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. raffaellamichelarinaldi@gmail.com.

Zitieren

APA

Autorino, R., Macchia, G., Russo, L., Dinapoli, N., Lancellotta, V., Bizzarri, N., Gabriella Ferrandina, M., Campitelli, M., De Luca, V., Giannini, R., Michela Rinaldi, R., Sala, E., Gui, B., & Antonietta Gambacorta, M. (2025). Which is the best timing to assess response after chemoradiation in locally advanced cervical cancer (BRILACC)?. Strahlentherapie und Onkologie. https://doi.org/10.1007/s00066-025-02463-3

Vancouver

Autorino R, Macchia G, Russo L, Dinapoli N, Lancellotta V, Bizzarri N, et al. Which is the best timing to assess response after chemoradiation in locally advanced cervical cancer (BRILACC)?. Strahlentherapie und Onkologie. 2025. doi:10.1007/s00066-025-02463-3

BibTeX
@article{Autorino2025,
  author = {Autorino, Rosa and Macchia, Gabriella and Russo, Luca and Dinapoli, Nicola and Lancellotta, Valentina and Bizzarri, Nicolò and Gabriella Ferrandina, Maria and Campitelli, Maura and De Luca, Viola and Giannini, Roberta and Michela Rinaldi, Raffaella and Sala, Evis and Gui, Benedetta and Antonietta Gambacorta, Maria},
  title = {Which is the best timing to assess response after chemoradiation in locally advanced cervical cancer (BRILACC)?},
  journal = {Strahlentherapie und Onkologie},
  year = {2025},
  doi = {10.1007/s00066-025-02463-3}
}
Kostenlos starten →